122 related articles for article (PubMed ID: 34897491)
1. High incidence of serious infections requiring hospitalisation in human T-cell leukaemia virus type 1-positive rheumatoid arthritis: A case-controlled observational study.
Hashiba Y; Umekita K; Kimura M; Iwao C; Iwao K; Kariya Y; Kubo K; Miyauchi S; Kudou R; Rikitake Y; Kawaguchi T; Matsuda M; Takajo I; Inoue E; Hidaka T; Okayama A
Mod Rheumatol; 2022 Aug; 32(5):866-874. PubMed ID: 34897491
[TBL] [Abstract][Full Text] [Related]
2. HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study.
Umekita K; Hashikura Y; Takaki A; Kimura M; Kawano K; Iwao C; Miyauchi S; Kawaguchi T; Matsuda M; Hashiba Y; Hidaka T
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851682
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
Umekita K; Hashiba Y; Iwao K; Iwao C; Kimura M; Kariya Y; Kubo K; Miyauchi S; Kudou R; Rikitake Y; Takajo K; Kawaguchi T; Matsuda M; Takajo I; Inoue E; Hidaka T; Okayama A
PLoS One; 2020; 15(5):e0233159. PubMed ID: 32459801
[TBL] [Abstract][Full Text] [Related]
4. The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study.
Iwamoto N; Araki T; Umetsu A; Takatani A; Aramaki T; Ichinose K; Terada K; Hirakata N; Ueki Y; Kawakami A; Eguchi K
Front Immunol; 2022; 13():887783. PubMed ID: 35603142
[TBL] [Abstract][Full Text] [Related]
5. The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study.
Umekita K; Hashiba Y; Kariya Y; Kubo K; Miyauchi S; Aizawa A; Umeki K; Nomura H; Kawaguchi T; Matsuda M; Takajo I; Hidaka T; Okayama A
Mod Rheumatol; 2019 Sep; 29(5):795-801. PubMed ID: 30246572
[No Abstract] [Full Text] [Related]
6. Effect of HTLV-1 Infection on the Clinical Course of Patients with Rheumatoid Arthritis.
Umekita K
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891440
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and human T-cell leukemia virus type-1 (HTLV-1) proviral load in HTLV-1-positive patients with rheumatoid arthritis: Baseline data in a single center cohort study.
Eguchi K; Iwanaga M; Terada K; Aramaki T; Tuji Y; Kurushima S; Kojima K; Arima K; Iwamoto N; Ichinose K; Kawakami A; Hirakata N; Ueki Y
Mod Rheumatol; 2020 May; 30(3):471-480. PubMed ID: 30938551
[No Abstract] [Full Text] [Related]
8. Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis.
Umekita K; Hidaka T; Miyauchi S; Ueno S; Kubo K; Takajo I; Hashiba Y; Kai Y; Nagatomo Y; Okayama A
Arthritis Care Res (Hoboken); 2014 May; 66(5):788-92. PubMed ID: 24127184
[TBL] [Abstract][Full Text] [Related]
9. Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series.
Umekita K; Umeki K; Miyauchi S; Ueno S; Kubo K; Kusumoto N; Takajo I; Nagatomo Y; Okayama A
Mod Rheumatol; 2015 Sep; 25(5):794-7. PubMed ID: 24252020
[TBL] [Abstract][Full Text] [Related]
10. Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis.
Suzuki T; Fukui S; Umekita K; Miyamoto J; Umeda M; Nishino A; Okada A; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Fujikawa K; Aramaki T; Mizokami A; Matsuoka N; Ueki Y; Eguchi K; Sato S; Hidaka T; Origuchi T; Okayama A; Kawakami A; Nakamura H
Arthritis Rheumatol; 2018 Jul; 70(7):1014-1021. PubMed ID: 29471588
[TBL] [Abstract][Full Text] [Related]
11. Association of human T-cell leukemia virus type 1 with prevalent rheumatoid arthritis among atomic bomb survivors: A cross-sectional study.
Hida A; Imaizumi M; French B; Ohishi W; Haruta D; Eguchi K; Nakamura H; Kawakami A
Medicine (Baltimore); 2021 Jun; 100(24):e26297. PubMed ID: 34128866
[TBL] [Abstract][Full Text] [Related]
12. A case of acute diffuse large B cell lymphoma in an anti-human T-cell leukaemia virus type 1-positive rheumatoid arthritis patient treated with methotrexate, who died.
Yoshida N; Sugiyama G; Sugi S; Satake K; Wakasugi D; Yamasaki S; Mihara Y; Matsuda K; Ida H; Ohshima K; Yamaguchi R; Nakashima M
Mod Rheumatol Case Rep; 2020 Jul; 4(2):161-167. PubMed ID: 33087004
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritis.
Endo Y; Fukui S; Umekita K; Suzuki T; Miyamoto J; Morimoto S; Shimizu T; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Okada A; Fujikawa K; Mizokami A; Matsuoka N; Aramaki T; Ueki Y; Eguchi K; Kariya Y; Hashiba Y; Hidaka T; Okayama A; Kawakami A; Nakamura H
Mod Rheumatol; 2021 Sep; 31(5):972-978. PubMed ID: 33161771
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HTLV-I Tax in a subset of patients with rheumatoid arthritis.
Zucker-Franklin D; Pancake BA; Brown WH
Clin Exp Rheumatol; 2002; 20(2):161-9. PubMed ID: 12051394
[TBL] [Abstract][Full Text] [Related]
15. Trends in serious infections in rheumatoid arthritis.
Ni Mhuircheartaigh OM; Matteson EL; Green AB; Crowson CS
J Rheumatol; 2013 May; 40(5):611-6. PubMed ID: 23547208
[TBL] [Abstract][Full Text] [Related]
16. High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis.
Eguchi K; Origuchi T; Takashima H; Iwata K; Katamine S; Nagataki S
Arthritis Rheum; 1996 Mar; 39(3):463-6. PubMed ID: 8607895
[TBL] [Abstract][Full Text] [Related]
17. Clonal expansion of gammadelta-T lymphocytes in an HTLV-I carrier, associated with chronic neutropenia and rheumatoid arthritis.
Horiuchi T; Hirokawa M; Satoh K; Kitabayashi A; Muira AB
Ann Hematol; 1999 Feb; 78(2):101-4. PubMed ID: 10089029
[TBL] [Abstract][Full Text] [Related]
18.
Hashiba Y; Umekita K; Minami H; Kawano A; Nagayasu E; Maruyama H; Hidaka T; Okayama A
Mod Rheumatol Case Rep; 2021 Jan; 5(1):16-21. PubMed ID: 32772699
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II.
Roucoux DF; Wang B; Smith D; Nass CC; Smith J; Hutching ST; Newman B; Lee TH; Chafets DM; Murphy EL;
J Infect Dis; 2005 May; 191(9):1490-7. PubMed ID: 15809908
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis.
Bailer RT; Lazo A; Harisdangkul V; Ehrlich GD; Gray LS; Whisler RL; Blakeslee JR
J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
